# US 2012/0252124 A1 · Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252124 A1
- Document ID: US20120252124A1
- Status: Published application
- Kind: A1
- Application number: 13/523,997
- Filed: 2012-06-15
- Published: 2012-10-04
- Earliest claimed: 2007-10-04
- Assignees: E. I. Du Pont de Nemours and Company
- Inventors: KNUT MEYER
- Web page: https://patentgrep.com/patent/US20120252124A1

## CPC

- C12N 15/79: Vectors or expression systems specially adapted for eukaryotic hosts
- A61K 31/355: Tocopherols, e.g. vitamin E
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 15/8243: {involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Preparation and use of isolated nucleic acids useful in altering the oil phenotype of plants are described. Isolated nucleic acids and their encoded polypeptides are described that alter the content of alpha-tocotrienol, beta-tocotrienol, or both, in transformed seeds and oil obtained from the transformed seeds. Expression cassettes, host cells and transformed plants are described that contain the foregoing nucleic acids.

## Claims

### Claim at position 1

1-28. (canceled)

### Claim 29

A transformed microbial cell comprising in its genome:
(a) a first recombinant nucleic acid molecule comprising at least one regulatory sequence operably linked to at least one nucleotide sequence selected from the group consisting of:
(i) a nucleotide sequence encoding a polypeptide having gamma-tocopherol methyltransferase activity;
(ii) a nucleotide sequence set forth in SEQ ID NOs: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37 or 39;
(iii) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NOs: 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 or 40;
(iv) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in any one of (i)-(iii), wherein the nucleotide sequence encodes a polypeptide having gamma-tocopherol methyltransferase activity; and
(v) a nucleotide sequence that is fully complementary to the nucleotide sequence of any one of (i)-(iv);
(b) a second recombinant nucleic acid molecule comprising at least one regulatory sequence operably linked to at least one nucleotide sequence selected from the group consisting of:
(vi) a nucleotide sequence encoding a polypeptide having homogentisate geranylgeranyl transferase activity;
(vii) a nucleotide sequence set forth in SEQ ID NOs: 1, 3, 5, 7, or 9;
(viii) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NOs: 2, 4, 6, 8, or 10;
(ix) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in any one of (vi)-(viii), wherein the nucleotide sequence encodes a polypeptide having homogentisate geranylgeranyl transferase activity; and
(x) a nucleotide sequence that is fully complementary to the nucleotide sequence of any one of (vi)-(ix); and
(c) a third recombinant nucleic acid molecule comprising at least one regulatory sequence operably linked to at least one nucleotide sequence selected from the group consisting of:
(xi) a nucleotide sequence encoding a polypeptide having 2-methyl-6-phytylbenzoquinol methyltransferase activity;
(xii) a nucleotide sequence set forth in SEQ ID NO:53;
(xiii) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NOs: 54, 61, 62, 63, 64, 65, 66, 67, 68, 69 or 70;
(xiv) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in any one of (xi)-(xii), wherein the nucleotide sequence encodes a polypeptide having 2-methyl-6-phytylbenzoquinol methyltransferase activity;
(xv) a nucleotide sequence encoding a polypeptide having 2-methyl-6-phytylbenzoquinol methyltransferase activity, wherein the amino acid sequence of the polypeptide has at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NOs: 54, 61, 62, 63, 64, 65, 66, 67, 68, 69 or 70; and
(xvi) a nucleotide sequence that is fully complementary to the nucleotide sequence of any one of (xi)-(xv);
wherein the first recombinant nucleic acid molecule, the second recombinant nucleic acid molecule and the third recombinant nucleic acid molecule are stably incorporated into the genome of the transformed microbial cell.

### Claim 30 (depends on 29)

The transformed microbial cell of claim 29, wherein said microbial cell is an algal cell.

### Claim 31 (depends on 29)

The transformed microbial cell of claim 29, wherein the at least one regulatory sequence of the first, second, and third recombinant nucleic acid molecules is a promoter.

### Claim 32

A method of increasing the level of alpha-tocotrienol, beta-tocotrienol, or both, in a microbial cell, comprising:
stably incorporating into microbial cell:
a. a first recombinant nucleic acid molecule comprising at least one regulatory sequence operably linked to at least one nucleotide sequence selected from the group consisting of:
(i) a nucleotide sequence encoding a polypeptide having gamma-tocopherol methyltransferase activity;
(ii) a nucleotide sequence set forth in SEQ ID NOs: 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37 or 39;
(iii) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NOs: 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38 or 40;
(iv) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in any one of (i)-(iii), wherein the nucleotide sequence encodes a polypeptide having gamma-tocopherol methyltransferase activity; and
(v) a nucleotide sequence that is complementary to the nucleotide sequence of any one of (i)-(iv);
(b) a second recombinant nucleic acid molecule comprising at least one regulatory sequence operably linked to at least one nucleotide sequence selected from the group consisting of:
(vi) a nucleotide sequence encoding a polypeptide having homogentisate geranylgeranyl transferase activity;
(vii) a nucleotide sequence set forth in SEQ ID NOs: 1, 3, 5, 7, or 9;
(viii) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NOs: 2, 4, 6, 8, or 10;
(ix) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in any one of (vi)-(viii), wherein the nucleotide sequence encodes a polypeptide having homogentisate geranylgeranyl transferase activity; and
(x) a nucleotide sequence that is complementary to the nucleotide sequence of any one of (vi)-(ix); and
(c) a third recombinant nucleic acid molecule comprising at least one regulatory sequence operably linked to at least one nucleotide sequence selected from the group consisting of:
(xi) a nucleotide sequence encoding a polypeptide having 2-methyl-6-phytylbenzoquinol methyltransferase activity;
(xii) a nucleotide sequence set forth in SEQ ID NO:53;
(xiii) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NOs: 54, 61, 62, 63, 64, 65, 66, 67, 68, 69 or 70;
(xiv) a nucleotide sequence having at least 80% sequence identity to the nucleotide sequence set forth in any one of (xi)-(xii), wherein the nucleotide sequence encodes a polypeptide having 2-methyl-6-phytylbenzoquinol methyltransferase activity;
(xv) a nucleotide sequence encoding a polypeptide having 2-methyl-6-phytylbenzoquinol methyltransferase activity, wherein the amino acid sequence of the polypeptide has at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NOs: 54, 61, 62, 63, 64, 65, 66, 67, 68, 69 or 70; and
(xvi) a nucleotide sequence that is fully complementary to the nucleotide sequence of any one of (xi)-(xv); and selecting a transformed microbial cell that has an increased level of alpha-tocotrienol, beta-tocotrienol, or both, relative to a microbial cell with a similar genetic background but lacking said first recombinant nucleic acid molecule, said second recombinant nucleic acid molecule and said third recombinant nucleic acid molecule.

### Claim 33 (depends on 32)

The method of claim 32, wherein said first, second and third recombinant nucleic acid molecules are incorporated into the microbial cell by transformation.

### Claim 34 (depends on 32)

The method of claim 32, wherein the at least one regulatory sequence of the first, second, and third recombinant nucleic acid molecules is a promoter.

### Claim 35 (depends on 32)

The method of claim 32, wherein the microbial cell is an algal cell.
